NCT05774899
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +6 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Recurrent Adenoid Cystic Carcinoma
Explore clinical trials studying Recurrent Adenoid Cystic Carcinoma. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
Recurrent Adenoid Cystic Carcinoma trial results
Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
NCT06118086
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +6 more
- Locations
-
- University of California San Francisco Helen Diller Comprehensive Cancer Center San Francisco, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Dana Farber Cancer Research Institute Boston, Massachusetts, United States
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
Not Yet Recruiting
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
NCT07521670
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adenoid Cystic Carcinoma Metastatic, +20 more
- Locations
-
- National Cancer Center Hospital Tokyo, Japan
- Sarawak General Hospital Kuching, Sarawak, Malaysia
- University of Malaya Medical Center Kuala Lumpur, Malaysia
- National Cancer Centre Singapore Singapore
Completed
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
NCT03990571
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Adenoid Cystic, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States